GFAP and early-onset autosomal dominant Alzheimer disease: There are studies that have reported higher levels of CSF GFAP in Alzheimer’s disease patients compared to healthy control subjects, reflecting the astrocytosis and degeneration of astrocytes [156,232,233,234].